{"id":"https://openalex.org/W1994269792","doi":"https://doi.org/10.1097/01.fjc.0000187176.13403.05","title":"Short-Term Pioglitazone Treatment Improves Vascular Function Irrespective of Metabolic Changes in Patients With Type 2 Diabetes","display_name":"Short-Term Pioglitazone Treatment Improves Vascular Function Irrespective of Metabolic Changes in Patients With Type 2 Diabetes","alternate_titles":[],"publication_year":2005,"publication_date":"2005-11-23","ids":{"openalex":"https://openalex.org/W1994269792","doi":"https://doi.org/10.1097/01.fjc.0000187176.13403.05","mag":"1994269792","pmid":"https://pubmed.ncbi.nlm.nih.gov/16306801"},"language":"en","primary_location":{"id":"doi:10.1097/01.fjc.0000187176.13403.05","doi":"https://doi.org/10.1097/01.fjc.0000187176.13403.05","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.fjc.0000187176.13403.05","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994269792"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075309331","display_name":"Fabrice M A C Martens","orcid":"https://orcid.org/0000-0002-0977-7276","observed_orcids":["https://orcid.org/0000-0002-0977-7276"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Fabrice M. A. C Martens","raw_affiliation_strings":["Department of Internal Medicine, Section of Vascular Medicine and Diabetology, University Medical Center, Utrecht, The Netherlands. fabrice.martens@wolmail.nl","Department of Internal Medicine, Section of Vascular Medicine and Diabetology, University Medical Center, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Section of Vascular Medicine and Diabetology, University Medical Center, Utrecht, The Netherlands. fabrice.martens@wolmail.nl","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Department of Internal Medicine, Section of Vascular Medicine and Diabetology, University Medical Center, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073320977","display_name":"Frank L.J. Visseren","orcid":"https://orcid.org/0000-0003-3951-5223","observed_orcids":["https://orcid.org/0000-0003-3951-5223"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Frank L. J Visseren","raw_affiliation_strings":["Department of Internal Medicine, Section of Vascular Medicine and Diabetology, University Medical Center, Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Section of Vascular Medicine and Diabetology, University Medical Center, Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038662049","display_name":"Eelco J.P. de Koning","orcid":"https://orcid.org/0000-0002-1232-7022","observed_orcids":["https://orcid.org/0000-0002-1232-7022"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eelco J. P de Koning","raw_affiliation_strings":["Department of Medicine, Division of Endocrinology and Metabolism, Leiden University Medical Center, Leiden, The Netherlands","Department of Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Endocrinology and Metabolism, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]},{"raw_affiliation_string":"Department of Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020130906","display_name":"Ton J. Rabelink","orcid":"https://orcid.org/0000-0001-6780-5186","observed_orcids":["https://orcid.org/0000-0001-6780-5186"]},"institutions":[{"id":"https://openalex.org/I2800006345","display_name":"Leiden University Medical Center","ror":"https://ror.org/05xvt9f17","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800006345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ton J Rabelink","raw_affiliation_strings":["Department of Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, The Netherlands","institution_ids":["https://openalex.org/I2800006345"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5073320977","https://openalex.org/A5075309331"],"corresponding_institution_ids":["https://openalex.org/I3018483916"],"apc_list":null,"apc_paid":null,"fwci":6.8371,"has_fulltext":false,"cited_by_count":108,"citation_normalized_percentile":{"value":0.97307162,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"46","issue":"6","first_page":"773","last_page":"778"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.33570000529289246,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.33570000529289246,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.3212999999523163,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.10989999771118164,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9860000014305115},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9129999876022339},{"id":"https://openalex.org/keywords/vascular-function","display_name":"vascular function","score":0.7590000033378601},{"id":"https://openalex.org/keywords/flow-mediated-dilation","display_name":"flow-mediated dilation","score":0.9089999794960022},{"id":"https://openalex.org/keywords/brachial-artery","display_name":"brachial artery","score":0.9440000057220459},{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.9330000281333923},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8109999895095825},{"id":"https://openalex.org/keywords/free-fatty-acids","display_name":"free fatty acids","score":0.972000002861023},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9950000047683716},{"id":"https://openalex.org/keywords/chronic-low-grade-inflammation","display_name":"low-grade inflammation","score":0.859000027179718},{"id":"https://openalex.org/keywords/endothelium-independent-relaxation","display_name":"endothelium-independent relaxation","score":0.8790000081062317},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7049999833106995},{"id":"https://openalex.org/keywords/conduit-arteries","display_name":"conduit arteries","score":0.45500001311302185},{"id":"https://openalex.org/keywords/sex-differences-in-drug-response","display_name":"sex differences in drug response","score":0.42100000381469727}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9747377038002014},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7674620151519775},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.7547451853752136},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7457719445228577},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7305245995521545},{"id":"https://openalex.org/C2777604165","wikidata":"https://www.wikidata.org/wiki/Q503643","display_name":"Brachial artery","level":3,"score":0.6467110514640808},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.611105740070343},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.5871263742446899},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5450357794761658},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5352683067321777},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5237010717391968},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5126132369041443},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.4848400354385376},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.4757485091686249},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.34188783168792725},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.1963854432106018},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05492907762527466},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001916","descriptor_name":"Brachial Artery","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001916","descriptor_name":"Brachial Artery","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002097","descriptor_name":"C-Reactive Protein","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D005230","descriptor_name":"Fatty Acids, Nonesterified","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014664","descriptor_name":"Vasodilation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D052242","descriptor_name":"Adiponectin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/01.fjc.0000187176.13403.05","doi":"https://doi.org/10.1097/01.fjc.0000187176.13403.05","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.fjc.0000187176.13403.05","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:16306801","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16306801","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W63530261","https://openalex.org/W1965148671","https://openalex.org/W1968973887","https://openalex.org/W1990131827","https://openalex.org/W1993319380","https://openalex.org/W1997030483","https://openalex.org/W2008288517","https://openalex.org/W2015219110","https://openalex.org/W2015279471","https://openalex.org/W2028038659","https://openalex.org/W2037447341","https://openalex.org/W2038046469","https://openalex.org/W2040855107","https://openalex.org/W2054727930","https://openalex.org/W2055378578","https://openalex.org/W2112565592","https://openalex.org/W2142179136","https://openalex.org/W2147332678","https://openalex.org/W2152037109","https://openalex.org/W2159316372","https://openalex.org/W2164367541","https://openalex.org/W4240449862"],"related_works":["https://openalex.org/W1983199223","https://openalex.org/W1992237025","https://openalex.org/W2080167189","https://openalex.org/W2379106424","https://openalex.org/W2377372314","https://openalex.org/W2091836518","https://openalex.org/W2169823638","https://openalex.org/W2354971374","https://openalex.org/W2394210940","https://openalex.org/W2022916510"],"abstract_inverted_index":{"To":[0],"determine":[1],"whether":[2],"pioglitazone":[3,23,36,114,140,186,299],"influences":[4],"endothelial":[5,39,117,180,296,302],"function":[6,181],"directly,":[7],"we":[8],"examined":[9],"in":[10,25,41,49,58,84,101,124,138,263,304,310,316],"a":[11,65,99],"randomized,":[12,131],"crossover,":[13,132],"placebo-controlled,":[14,133],"double-blind":[15,134],"trial":[16,135],"the":[17,108,167,208,291],"effects":[18,83],"of":[19,22,45,52,103,110,113,166,293,308],"4":[20,111,159],"weeks":[21,112],"treatment":[24,37,115,187,213,300],"20":[26,148],"male":[27],"type":[28,59,87,127,151,317],"2":[29,60,88,128,152,209,318],"diabetic":[30],"patients.":[31],"We":[32,106],"conclude":[33],"that":[34],"short-term":[35],"ameliorates":[38,301],"dysfunction":[40,303],"conduit":[42,294,305],"arteries":[43,306],"irrespective":[44,307],"significant":[46,261],"beneficial":[47,81],"changes":[48,289,309],"plasma":[50,264],"levels":[51],"insulin,":[53,215,311],"FFA,":[54,216,312],"adiponectin,":[55,313],"or":[56,314],"CRP":[57,315],"patients":[61,85,125,149,319],"with":[62,86,126,150,189,222,320],"diabetes.":[63,89,129,321],"Pioglitazone,":[64],"PPARgamma":[66],"agonist,":[67],"not":[68,205],"only":[69],"improves":[70],"insulin":[71],"resistance":[72],"and":[73,95,121,217,246,290],"glycemic":[74],"control":[75],"but":[76],"may":[77,97],"also":[78,280],"have":[79],"additional":[80],"vascular":[82,104,176],"Low-grade":[90],"inflammation,":[91],"free":[92],"fatty":[93],"acids,":[94],"adiponectin":[96,265],"play":[98],"role":[100],"modulation":[102],"function.":[105,177,297],"studied":[107],"effect":[109],"on":[116,154],"function,":[118],"metabolic":[119,288],"changes,":[120],"C-reactive":[122,218],"protein":[123,219],"A":[130,260],"was":[136,145,170,182,204,279],"performed":[137],"which":[139],"30":[141],"mg":[142],"once":[143],"daily":[144],"administered":[146],"to":[147],"diabetes":[153],"oral":[155],"antihyperglycemic":[156],"agents":[157],"for":[158,175],"weeks.":[160],"Shear":[161],"stress-induced":[162],"flow-mediated":[163],"dilation":[164],"(FMD)":[165],"brachial":[168],"artery":[169,179,295],"used":[171],"as":[172],"outcome":[173],"parameter":[174],"Brachial":[178],"significantly":[183],"increased":[184],"by":[185],"compared":[188,221],"placebo":[190,223],"(FMD":[191],"5.4":[192],"+/-":[193,197,225,229,236,240,248,253,268,273],"0.5%":[194],"versus":[195,227,238,251,271],"3.1":[196],"0.5%,":[198],"P":[199,232,243,256,276],"=":[200,233,244,257,277],"0.001).":[201],"Endothelium-independent":[202],"vasodilation":[203],"different":[206],"between":[207,286],"study":[210],"periods.":[211],"Pioglitazone":[212],"reduced":[214],"concentrations":[220],"(18.3":[224],"2.4":[226],"14.8":[228],"2.1":[230],"mU/L,":[231],"0.03;":[234],"641":[235],"46":[237],"542":[239],"33":[241],"mumol/L,":[242],"0.04;":[245],"3.5":[247],"0.6":[249],"mg/L":[250],"2.6":[252],"0.5":[254],"mg/L,":[255],"0.01;":[258],"respectively).":[259],"increase":[262],"concentration":[266],"(3.95":[267],"0.57":[269],"microg/mL":[270],"7.59":[272],"0.95":[274],"microg/mL,":[275],"0.002)":[278],"observed.":[281],"No":[282],"correlations":[283],"were":[284],"found":[285],"these":[287],"improvement":[292],"Short-term":[298]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994269792","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
